A Clinical Trial Comparing the BAGUERA C to the Marketed Mobi-C® for the Treatment of Cervical Disc Disease at 2 Contiguous Levels

NAActive, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2030

Conditions
Cervical Disc Disease
Interventions
DEVICE

BAGUERA®C Cervical Disc Prosthesis

surgery

DEVICE

Mobi-C Cervical Disc

surgery

Trial Locations (26)

17601

Neurosurgical Associates of Lancaster, Lancaster

20057

Georgetown University Medical Center, Washington D.C.

28204

Carolina Neurosurgery and Spine Associates, Charlotte

30339

Legacy Brain & Spine, Atlanta

37404

Center for Sports Medicine & Orthopedics, Chattanooga

42001

Orthopaedic Institute of Western Kentucky, Paducah

43210

The Ohio State University - Dept of Orthadedics, Columbus

46032

Indiana Spine Group, Carmel

46825

Ortho NorthEast, Fort Wayne

60201

NorthShore, Evanston

60612

Midwest Orthopedics at Rush, Chicago

71101

Spine Institute of Louisiana Foundation, Shreveport

78705

St. David's Healthcare, Austin

81657

Vail-Summit Orthopaedics and Neurosurgery, Vail

84088

The Disc Replacement Center, Salt Lake City

85023

MORE Foundation, Phoenix

85258

Desert Institute for Spine Care, Scottsdale

90403

The Spine Institute, Center for Spine Restoration, Santa Monica

91307

Institute for Neuro Innovation, West Hills

92270

Eisenhower Medical Center, Rancho Mirage

92653

BEEL Medical, Laguna Hills

92691

Orange County Neurosurgical Associates, Mission Viejo

92868

UCI Health, Orange

97062

Oregon Spine Care, Tualatin

98122

Swedish Neuroscience, Swedish Spine Institute, Seattle

06518

Hartford Health CT Orthopaedics, Hamden

All Listed Sponsors
lead

Spineart USA

INDUSTRY